Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8649634rdf:typepubmed:Citationlld:pubmed
pubmed-article:8649634lifeskim:mentionsumls-concept:C0019163lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C1524112lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C0042196lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C1522475lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C0442117lld:lifeskim
pubmed-article:8649634lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:8649634pubmed:issue1lld:pubmed
pubmed-article:8649634pubmed:dateCreated1996-7-23lld:pubmed
pubmed-article:8649634pubmed:abstractTextTo determine whether hepatitis B vaccination given intracutaneously (i.c.) is more effective than intramuscularly (i.m.) in primary non-responding haemodialysis patients.lld:pubmed
pubmed-article:8649634pubmed:languageenglld:pubmed
pubmed-article:8649634pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8649634pubmed:citationSubsetIMlld:pubmed
pubmed-article:8649634pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8649634pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8649634pubmed:statusMEDLINElld:pubmed
pubmed-article:8649634pubmed:monthJanlld:pubmed
pubmed-article:8649634pubmed:issn0931-0509lld:pubmed
pubmed-article:8649634pubmed:authorpubmed-author:ChangP CPClld:pubmed
pubmed-article:8649634pubmed:authorpubmed-author:van LeerEElld:pubmed
pubmed-article:8649634pubmed:authorpubmed-author:van DorpW TWTlld:pubmed
pubmed-article:8649634pubmed:authorpubmed-author:Schrander-van...lld:pubmed
pubmed-article:8649634pubmed:issnTypePrintlld:pubmed
pubmed-article:8649634pubmed:volume11lld:pubmed
pubmed-article:8649634pubmed:ownerNLMlld:pubmed
pubmed-article:8649634pubmed:authorsCompleteYlld:pubmed
pubmed-article:8649634pubmed:pagination191-3lld:pubmed
pubmed-article:8649634pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:meshHeadingpubmed-meshheading:8649634-...lld:pubmed
pubmed-article:8649634pubmed:year1996lld:pubmed
pubmed-article:8649634pubmed:articleTitleIntracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients.lld:pubmed
pubmed-article:8649634pubmed:affiliationUniversity Hospital Leiden, Kennemer Gasthuis, Haarlem, The Netherlands.lld:pubmed
pubmed-article:8649634pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8649634pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8649634pubmed:publicationTypeRandomized Controlled Triallld:pubmed